Sex-based differences in adverse left ventricular remodelling and clinical outcomes after ST-segment elevation myocardial infarction

Fecha de publicación: 01/05/2025 Fecha Ahead of Print: 01/02/2025

Autores de INCLIVA

Participantes ajenos a INCLIVA

Tello, AA
Sambola, A
Valente, F
Sao, A
Ródenas-Alesina, E
Rello, P
Maymi, M
Barrabés, JA
Otaegui, I
del Blanco, BG
Morr-Verenzuela, CI
Lorenzatti, D
Ortiz-Pérez, JT
Rodríguez-Palomares, JF
Ferreira-González, I

Grupos y Plataformas de I+D+i

Grupo de Investigación Traslacional en Cardiopatía Isquémica

Leading Researcher

Vicent Bodí Peris

Abstract

Aims The impact of sex on adverse left ventricular remodelling (LVR) after ST-elevation myocardial infarction (STEMI) is unclear due to conflicting results. This study sought to establish sex-based differences in adverse LVR using cardiovascular magnetic resonance (CMR) among STEMI patients and their impact on clinical outcomes. Methods and results The study included patients with a first STEMI who underwent primary percutaneous coronary intervention (PCI). Cardiovascular magnetic resonance was performed at 6 days (interquartile range [IQR]: 4-9 days) and after 6 months (6.42 months; IQR: 5.98-7.47 months). Follow-up was 6.94 years (IQR: 4.48-9.32 years). The primary endpoint was the presence of adverse LVR (>15% of LV end-diastolic volume and a decrease of >3% in LV ejection fraction) at 6 months. The secondary endpoint was major adverse cardiac events (MACEs), defined as a combined variable: cardiovascular death, heart failure admission, or ventricular arrhythmias. One thousand sixty-seven patients were included (17.5% women; mean age: 58.71 +/- 11.85 years). Women were older and had more cardiovascular risk factors (CVRF). There was no association between sex and adverse LVR [OR: 0.80; 95% confidence interval (CI), 0.39-1.64; P = 0.536]. Major adverse cardiac events occurred in 177 patients (16.7%) and was more frequent in women (22.6% vs. 15.4%; P = 0.017). However, after adjusting for baseline differences and CVRF, the female sex was not associated with MACE (hazard ratio: 1.21; 95% CI, 0.81-1.81; P = 0.343). Conclusion The higher rate of MACE after STEMI in women compared to men appears to be associated with a higher prevalence of CVRF and comorbidities rather than a more significant occurrence of adverse LVR.

© The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.